Jeffrey Allen Bailey Insider Trading
Get free email notifications about insider trading for Jeffrey Allen Bailey.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey Allen Bailey. Jeffrey Allen Bailey is a Director in LANDAUER INC ($LDR) and a Director in TEKLA HEALTHCARE INVESTORS ($HQH) and a Director in TEKLA LIFE SCIENCES INVESTORS ($HQL) and a Chief Commercial Officer in KING PHARMACEUTICALS INC ($KG) and an Chief Executive Officer in BIODELIVERY SCIENCES INTERNATIONAL INC ($BDSI) and a Director in BIODELIVERY SCIENCES INTERNATIONAL INC ($BDSI) and a Director in AILERON THERAPEUTICS INC ($ALRN) and a CEO and President in Lantheus Holdings, Inc. ($LNTH) and a Director in Tekla Healthcare Opportunities Fund ($THQ) and a Director in Tekla World Healthcare Fund ($THW).
Address: 501 FIFTH STREET BRISTOL 37620 TN
Companies in which Jeffrey Allen Bailey is an Insider
AILERON THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey Allen Bailey: Director
Holdings: 35,752 shares
Latest Transaction: Jun 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIODELIVERY SCIENCES INTERNATIONAL INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey Allen Bailey: Chief Executive Officer, Director
Holdings: 35,567 shares
Current Value: $69,356
Latest Transaction: Dec 16 2020
$BDSI Market Capitalization: $106.88M
$BDSI Previous Close: $1.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KING PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey Allen Bailey: Chief Commercial Officer
Holdings: 0 shares
Latest Transaction: Feb 02 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LANDAUER INC
Industry: MEASURING & CONTROLLING DEVICES, NEC [3829]
Position of Jeffrey Allen Bailey: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 19 2017
$LDR Market Capitalization: $477.20M
$LDR Previous Close: $50.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Lantheus Holdings, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Jeffrey Allen Bailey: CEO and President
Holdings: 60,933 shares
Current Value: $548,397
Latest Transaction: Aug 31 2015
$LNTH Market Capitalization: $323.30M
$LNTH Previous Close: $9.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TEKLA HEALTHCARE INVESTORS
Industry:
Position of Jeffrey Allen Bailey: Director
Holdings: 490 shares
Latest Transaction: Sep 23 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Tekla Healthcare Opportunities Fund
Industry:
Position of Jeffrey Allen Bailey: Director
Holdings: 570 shares
Latest Transaction: Sep 23 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TEKLA LIFE SCIENCES INVESTORS
Industry:
Position of Jeffrey Allen Bailey: Director
Holdings: 580 shares
Latest Transaction: Sep 23 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Tekla World Healthcare Fund
Industry:
Position of Jeffrey Allen Bailey: Director
Holdings: 980 shares
Latest Transaction: Apr 08 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jeffrey Allen Bailey
Sentiment: All, ALRN, BDSI, KG, LDR, LNTH, HQH, THQ, HQL, THW
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 08 2021 | THW | Tekla World Health ... | Bailey Jeffrey Allen | Director | Option Exercise | X | 14.26 | 735 | 10,483 | 0 | |
| Apr 08 2021 | THW | Tekla World Health ... | Bailey Jeffrey Allen | Director | Buy | X | 14.26 | 245 | 3,494 | 980 | 735 to 980 (+33.33 %) |
| Dec 16 2020 | BDSI | BIODELIVERY SCIENC ... | Bailey Jeffrey Allen | Chief Executive Off ... | Sell | S | 4.35 | 10,000 | 43,500 | 35,567 | 45.6 K to 35.6 K (-21.95 %) |
| Nov 06 2020 | BDSI | BIODELIVERY SCIENC ... | Bailey Jeffrey Allen | Chief Executive Off ... | Option Exercise | A | 0.00 | 160,000 | 0 | 160,000 | |
| Nov 06 2020 | BDSI | BIODELIVERY SCIENC ... | Bailey Jeffrey Allen | Chief Executive Off ... | Option Exercise | A | 3.60 | 840,000 | 3,024,000 | 840,000 | |
| Nov 06 2020 | BDSI | BIODELIVERY SCIENC ... | Bailey Jeffrey Allen | Chief Executive Off ... | Option Exercise | M | 0.00 | 40,000 | 0 | 0 | |
| Nov 06 2020 | BDSI | BIODELIVERY SCIENC ... | Bailey Jeffrey Allen | Chief Executive Off ... | Buy | M | 0.00 | 40,000 | 0 | 45,567 | 5.6 K to 45.6 K (+718.52 %) |